Point72 Asset
View Older Stories View More Recent Stories
-
Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Amylyx Pharmaceuticals, Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A ANGIODYNAMICS INC Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Zepp Health Corp Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Teladoc Health, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Arcus Biosciences, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Ventyx Biosciences, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Entera Bio Ltd. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A TOWER SEMICONDUCTOR LTD Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A PagSeguro Digital Ltd. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Sphere Entertainment Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A LENZ Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Xilio Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A WOLVERINE WORLD WIDE Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Invivyd, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A KALA BIO, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Praxis Precision Medicin Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G Black Rock Coffee Bar, Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G Galecto, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G PALATIN TECHNOLOGIES Filed by: Point72 Asset Management, L.P.
-
Point72 increases Lionsgate Studios stake to 14.7 million shares
-
Form SCHEDULE 13G Lionsgate Studios Corp. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G TENAX THERAPEUTICS, INC. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G C4 Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G WOLFSPEED, INC. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G PALISADE BIO, INC. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G Aptevo Therapeutics Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G Dianthus Therapeutics, Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G KALA BIO, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G FG Nexus Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G PLIANT THERAPEUTICS, Filed by: Point72 Asset Management, L.P.
-
Form N-PX Point72 Asset Management For: Jun 30
-
Form SCHEDULE 13G WOLVERINE WORLD WIDE Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G Design Therapeutics, Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G Invivyd, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G iBio, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G Kodiak Sciences Inc. Filed by: Point72 Asset Management, L.P.
-
Point72 Asset Management files schedule 13G reporting 4.0% stake in ALT5 Sigma
-
Form SCHEDULE 13G Syndax Pharmaceuticals Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G ALT5 Sigma Corp Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Syndax Pharmaceuticals Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A VNET Group, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Shoals Technologies Grou Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Cidara Therapeutics, Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Lumentum Holdings Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A CYBIN INC. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Regulus Therapeutics Filed by: Point72 Asset Management, L.P.

